Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology Terms update on 18 Dec 2026

Peptide Comparison

Cortagen vs Livagen

Editorial breakdown of mechanism, evidence, decision criteria, and the misconceptions worth calling out.

Data-derived verdict

Cortagen and Livagen share the khavinson class and carry roughly equivalent evidence (Russian Research / Russian Research). The catalogued data does not favor one over the other; pick based on practical fit: route, dosing schedule, cost, regulatory framing, or which specific receptor sub-target matters most for the intended research use.

Generated from catalog evidence-tier data, not editorial judgment. Both compounds share at least one mechanism class and this verdict reads the catalogued evidence tier of each, not specific trial nuance.

Evidence at a glance

Cortagen

Russian Research

Livagen

Russian Research

FDA-approved   Phase 3   Phase 2 / approved abroad   Anecdotal + animal   Preclinical / flagged

Side-by-side

Cortagen Livagen
Class Khavinson short peptide bioregulator Khavinson short peptide bioregulator
Drug class Cognitive Tissue Repair
Mechanism Tissue-specific gene expression in cerebral cortex Chromatin decondensation in hepatocytes; gene expression modulation
Route Oral / SC Oral
Half-life Short (minutes) Short (minutes)
Dosage (research) Oral capsule 1-2x daily Oral capsule 1-2x daily
Evidence tier Russian Research Russian Research
Research depth 15 indexed (PubMed 13 · CT 0 · EPMC 2) 20 indexed (PubMed 18 · CT 0 · EPMC 2)
Availability Research Research
Reported risks Limited Western evidence Sparse clinical data

Reported research data only. "Studied for" and "reported in literature" describe published research focus, not clinical recommendation. Most peptides catalogued here are not FDA-approved for human use.

Frequently asked questions

Should I pick Cortagen or Livagen?

Cortagen and Livagen share the khavinson class and carry roughly equivalent evidence (Russian Research / Russian Research). The catalogued data does not favor one over the other; pick based on practical fit: route, dosing schedule, cost, regulatory framing, or which specific receptor sub-target matters most for the intended research use.

What is the difference between Cortagen and Livagen?

Cortagen is classed as Khavinson short peptide bioregulator; Livagen is classed as Khavinson short peptide bioregulator. Reported mechanism: Cortagen, Tissue-specific gene expression in cerebral cortex; Livagen, Chromatin decondensation in hepatocytes; gene expression modulation. Reported half-life: Cortagen, Short (minutes); Livagen, Short (minutes). Routes in published studies: Cortagen, Oral / SC; Livagen, Oral.

Which has stronger evidence, Cortagen or Livagen?

Cortagen and Livagen sit on the same rung of PeptideHelper.org's five-step evidence scale, which runs from preclinical to FDA-approved. Cortagen is graded Russian Research, with 2 cited sources on its reference page and 15 indexed studies. Livagen is graded Russian Research, with 2 cited sources on its reference page and 20 indexed studies.

Which is more accessible, Cortagen or Livagen?

Neither Cortagen nor Livagen is an FDA-approved drug. Catalog status: Cortagen, Research; Livagen, Research.

Are Cortagen and Livagen ever combined?

Cortagen and Livagen appear together in no stack catalogued on PeptideHelper.org, and the interaction engine raises no flag for the pair.

Open the PeptideHelper.org compare tool to add more compounds to this side-by-side and filter by evidence tier interactively.

Loading interactive view…